Akzo Nobel N.V. (AKZOY)

QUOTE AND NEWS
Financial Times  Jun 4  Comment 
Investors sceptical Dutch group will deliver greater value as independent entity
Channel News Asia  Jun 2  Comment 
Akzo Nobel, the Dutch paint maker that rejected a 26.3 billion-euro (US$29.6 billion) takeover proposal from U.S. rival PPG Industries , has sent PPG a letter shortly after its suitor walked away, detailing its objections to doing a deal.
Reuters  Jun 1  Comment 
In early March, U.S. paint maker PPG 's Chief Executive Michael McGarry flew from Pittsburgh to Amsterdam to take Akzo Nobel boss Ton Buechner for lunch.
Financial Times  Jun 1  Comment 
PPG chief outmanoeuvred by Dutch rival Büchner in bitter €26.9bn takeover tussle
Wall Street Journal  Jun 1  Comment 
Akzo Nobel group’s refusal to enter talks with U.S. peer PPG Industries has laid bare not just the board’s lack of commitment to owners’ interests but also the protection from shareholder pressure afforded by the company’s capital...
New York Times  Jun 1  Comment 
The American paint and chemicals giant said it would not make a formal bid, after its Dutch rival repeatedly rejected its approaches.




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Based in the Netherlands, Akzo Nobel N.V.is a Global Fortune 500 chemicals company, producing a vast array of goods such as human and animal pharmaceuticals, paints, stains, hospital supplies, and other products. The company operates three business segments: Coatings, Chemicals, and Pharma. The Coatings segment makes decorative, industrial and protective coatings, as well as industrial finishes, car refinishes, and other industrial products. The Chemicals segment produces specialty, functional, and commodity chemicals. Its products include pulp and paper, surfactants, polymers and base chemicals, as well as high-quality salts. The Pharma segment is engaged in research, development, manufacturing, sales and services in strategic areas of human and animal healthcare. The Pharma business is named as Organon Biosciences (OBS). This segment comprises two units: Organon, which makes prescription medicines and produces complex active pharmaceutical ingredients and Intervet, which manufactures veterinary products.

Comparison to Competitors


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki